We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
The drug daraxonacib doubled survival in pancreatic cancer but does not cure. Learn about mechanisms, side effects, and real limits of the breakthrough. Read the analysis.
